
Manuel Marina Breysse, MD, MSc
Creating knowledge, science and technology by building safe and high-performance artificial intelligence systems for electrocardiogram analysis; to make medical grade AI helpful for everyone, everywhere in the world.
Manuel Marina Breysse, MD, MSc
Creating knowledge, science and technology by building safe and high-performance artificial intelligence systems for electrocardiogram analysis; to make medical grade AI helpful for everyone, everywhere in the world.
CLASS OF 2024
COMPANY
Idoven
Co-Founder & CEO
LOCATION
Madrid, Spain
AREA OF FOCUS
Cardiovascular disease, artificial intelligence, electrocardiography, signal processing
BIO
Dr. Manuel Marina Breysse is a cardiologist, CEO and co-founder of Idoven, a health technology company advancing early detection and precision medicine for cardiovascular diseases. Manuel and his co-founders started Idoven in 2018 after conducting basic and translational research at the National Center for Cardiovascular Research (CNIC) in Spain focused on machine learning applied to cardiology.
As a cardiologist, Manuel is specialized in arrhythmias and high-performance sports cardiology and has been a doctor at the Spanish Agency for Health Protection in Sports (AEPSAD). He is also a member of the European Society of Cardiology, an Associate Partner of the Spanish Society of Cardiology, and scientist at the Cardiovascular Disease Network Biomedical Research Center (CIBERCV). Manuel has published over 20 scientific papers, received a MS in Statistics from the University of Cordoba and MD from the University of Alcalá in Spain.